Tag: Revenue

Angel One net profit rises 30.6% in Q4 to Rs 340 crore

 stock analyst  04/18/2024  0 Comments on Angel One net profit rises 30.6% in Q4 to Rs 340 crore

Consolidated revenue from operations jumped 28.15% to 1,357.2 crore from the December quarter. Net profit in January-March was up 27.3% and revenue from operations was up 64.3% from last year

Omnicom Q1 adjusted EPS beats estimates, revenue up 5.4% YoY

 stock analyst  04/17/2024  0 Comments on Omnicom Q1 adjusted EPS beats estimates, revenue up 5.4% YoY

NEW YORK – Omnicom Group Inc. (NYSE: NYSE:OMC) announced its first-quarter earnings, surpassing analyst expectations with an adjusted EPS of $1.67, which was $0.13 higher than the consensus estimate of $1.54. Revenue for the quarter also exceeded forecasts, coming in at $3.63 billion against the anticipated $3.61 billion.

JB Hunt misses Q1 earnings, revenue forecasts

 stock analyst  04/17/2024  0 Comments on JB Hunt misses Q1 earnings, revenue forecasts

LOWELL, Ark. – J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT) reported a decline in its first quarter 2024 earnings and revenue, missing analyst expectations. The company\’s earnings per share (EPS) came in at $1.22, falling short of the consensus estimate of $1.52 by $0.30. Revenue for the quarter was $2.94 billion, also below the analyst forecast of $3.12 billion.

Earnings call: BNY Mellon reports solid Q1 with EPS and revenue growth

 stock analyst  04/17/2024  0 Comments on Earnings call: BNY Mellon reports solid Q1 with EPS and revenue growth

BNY Mellon (NYSE: BK) delivered a strong performance in the first quarter of 2024, with a 3% year-over-year (YoY) increase in total revenue to $4.5 billion and an 11% rise in earnings per share (EPS) to $1.25. The company experienced growth across various segments, including investment services fees and a notable 8% increase in servicing fees.

J&J earnings beat by $0.07, revenue fell short of estimates

 stock analyst  04/16/2024  0 Comments on J&J earnings beat by $0.07, revenue fell short of estimates

Investing.com – J&J (NYSE: JNJ) reported first quarter EPS of $2.71, $0.07 better than the analyst estimate of $2.64. Revenue for the quarter came in at $21.38B versus the consensus estimate of $21.4B.

Bank of NY Mellon earnings beat by $0.10, revenue topped estimates

 stock analyst  04/16/2024  0 Comments on Bank of NY Mellon earnings beat by $0.10, revenue topped estimates

Investing.com – Bank of NY Mellon (NYSE: BK) reported first quarter EPS of $1.29, $0.10 better than the analyst estimate of $1.19. Revenue for the quarter came in at $4.53B versus the consensus estimate of $4.38B.

PNC Financial earnings beat by $0.34, revenue fell short of estimates

 stock analyst  04/16/2024  0 Comments on PNC Financial earnings beat by $0.34, revenue fell short of estimates

Investing.com – PNC Financial (NYSE: PNC) reported first quarter EPS of $3.36, $0.34 better than the analyst estimate of $3.02. Revenue for the quarter came in at $5.15B versus the consensus estimate of $5.19B.

Bank of America earnings matched, revenue topped estimates

 stock analyst  04/16/2024  0 Comments on Bank of America earnings matched, revenue topped estimates

Investing.com – Bank of America (NYSE: BAC) reported first quarter EPS of $0.76, in line with the analyst estimate of $0.76. Revenue for the quarter came in at $25.8B versus the consensus estimate of $25.49B.

Bank of America earnings beat by $0.07, revenue topped estimates

 stock analyst  04/16/2024  0 Comments on Bank of America earnings beat by $0.07, revenue topped estimates

Investing.com – Bank of America (NYSE: BAC) reported first quarter EPS of $0.83, $0.07 better than the analyst estimate of $0.76. Revenue for the quarter came in at $25.8B versus the consensus estimate of $25.49B.

J&J first-quarter revenue misses as Stelara sales disappoint

 stock analyst  04/16/2024  0 Comments on J&J first-quarter revenue misses as Stelara sales disappoint

(Reuters) -Johnson & Johnson reported quarterly revenue below analysts\’ estimates as sales from its blockbuster psoriasis drug Stelara, which is expected to face competition from biosimilar versions in some markets later this year, fell short of expectations.

Bank of America meets earnings estimates, beats revenue expectations in Q1 2024

 stock analyst  04/16/2024  0 Comments on Bank of America meets earnings estimates, beats revenue expectations in Q1 2024

Shares of Bank of America (BAC) reported earnings and revenue results for the fiscal Q1 2024 earnings that exceeded Wall Street estimates.

Morgan Stanley earnings beat by $0.35, revenue topped estimates

 stock analyst  04/16/2024  0 Comments on Morgan Stanley earnings beat by $0.35, revenue topped estimates

Investing.com – Morgan Stanley (NYSE: MS) reported first quarter EPS of $2.02, $0.35 better than the analyst estimate of $1.67. Revenue for the quarter came in at $15.1B versus the consensus estimate of $14.42B.